Special Issue "Intranasal Administration: Potential Route as Diverse Targeting Systems"
Deadline for manuscript submissions: 10 November 2021.
Interests: nasal absorption; cervical lymph node targeting; lymphatic delivery; powdery formulation; peptide drug delivery; brain targeting
Interests: nasal absorption; nasal powder formulation; nose-to-brain; nasal drug delivery; mucosal absorption; cns drug delivery; formulation development; brain targeting
The intranasal administration route can deliver drugs directly to the brain, central nervous system (CNS) region, and the lymphatic tissues, as well as through mucosal absorption. The drug delivery system using the intranasal administration is a useful tool for the development of new treatment strategies for various diseases (e.g., CNS diseases, tumour, and acute pain). This Special Issue will address the advances of the nasal drug delivery system, focusing the development of the drug delivery system to various target tissues (e.g., nose-to-brain, nose-to lymph, mucosal absorption, and nasal topical use). In addition, this Issue includes not only drug targeting to the brain and lymph, but also nasal formulation development such as newly dosage forms (powder, mucoadhesion, gelation, micro (nano) particulation, etc.), intranasal dissolution, and mucosal permeation.
Dr. Tomoyuki Furubayashi
Dr. Daisuke Inoue
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Intranasal administration
- Brain targeting
- Lymphatic delivery
- Mucosal absorption
- Nasal formulation development
- Intranasal dissolution and permeation